News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Videos|October 8, 2020

World CME Conference™ Preview: The Interplay of Migraines and Psychiatric Disorders

Author(s)Heidi Moawad, MD

Enjoy this preview of Dr Moawad's talk for the upcoming CME Conference.

Dr Moawad is Associate Editor Humanities in Neurology, Clinical Assistant Professor Case Western Reserve University School of Medicine, Div. of Medical Education, and Editor in Chief Emeritus of Neurology Times (2017-2019).

Interested in hearing more? Join us at the Annual Psychiatric Times® World CME Conference™. Dr Moawad will be giving her talk, The Interplay of Migraines and Psychiatric Disorders: Treatment Implications, at 1:05 on Thursday, October 15, 2020. Register now!

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

1 expert is featured in this series.

Take-Home Messages: Clinical Confidence in Transitioning Patients to Cobenfy

ByDavid Walling, PhD

July 8th 2026

1 expert is featured in this series.

Managing Tolerability and Setting Patients Up for Success with Cobenfy

ByDavid Walling, PhD

July 1st 2026

pharmacogenomics

Psychiatric Pharmacogenomics: An Overview

ByAbby Ao, DO,James A. Bourgeois, OD, MD,John J. Miller, MD

June 23rd 2026

1 expert is featured in this series.

The Switch Study: Why a New Mechanism Demands a New Approach

ByDavid Walling, PhD

June 17th 2026

suicide

Narrative Crisis Model: A Suggested Redefinition of the Clinical Understanding of Suicidal Mental Process

ByJayashree Balasubramanian, MA, MS,Rawad El Hayek, MD,Igor Galynker, MD, PhD

May 20th 2026

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Trending on Psychiatric Times

Remlifanserin for the Treatment of Alzheimer Disease Psychosis Receives FDA Fast Track Designation

Targeting APOE4: A Promising Therapeutic Strategy for Alzheimer Disease

Future DSM Plans Overlook Core Problem of Validity

Classic Drug, New Target: Lithium as Disease-Modifying in Alzheimer Dementia

Bipolar Disorder in Women of Childbearing Age: Proper Treatment Before Pregnancy